当前位置:主页 > 医学论文 > 肿瘤论文 >

锑剂治疗急性早幼粒细胞白血病的优势作用研究

发布时间:2018-02-28 07:49

  本文关键词: 三氧化二砷 三氧化二锑 锑化合物 分化 砷剂 锑剂 出处:《浙江大学》2017年硕士论文 论文类型:学位论文


【摘要】:目的:1)研究锑剂在治疗急性早幼粒细胞白血病(APL)中的作用,探究锑剂对急性早幼粒细胞白血病相关蛋白的影响,进而证明锑剂具有治疗APL作用。2)通过探讨锑剂对PML突变体(例如A216V和L218P;砷剂耐药性突变体)的降解作用,发现具有更强降解PML突变体的锑化合物。方法:常规培养急性早幼粒细胞白血病NB4细胞后,使用三氧化二锑(简称锑剂)或砷剂(阳性对照)暴露NB4细胞,通过MTT法,瑞氏-吉姆萨染料染色,流式细胞术,Western Blot,免疫荧光等方法检测NB4细胞的增值抑制,分化、凋亡等指标变化。使用免疫荧光法检测锑剂对核小体形成的影响。利用HEK293T或HeLa细胞,转染Flag-PML或Flag-PML-RARa基因,过表达PML或PML-RARa融合蛋白,研究锑剂(或砷剂)对PML蛋白的溶性改变和降解作用。主要以RIPA buffer和LDS buffer分别提取可溶上清蛋白(RIPA可溶部分)和不溶沉淀蛋白(RIPA不可溶部分)。使用Western Blot法分别检测PML和PML-RARa融合蛋白在RIPA可溶和不溶部分中的变化和后修饰变化。结果:1)锑剂对NB4细胞的作用结果;MTT和流式细胞术结果显示,锑剂的细胞毒性明显弱于砷剂,而且锑剂有较强的诱导NB4细胞CD11b的表达(早有粒细胞分化标志蛋白)。同时,还发现锑剂可使NB细胞核形态变化,证明锑剂具有较强的诱导NB4细胞分化作用。随着锑剂暴露浓度的增加,胞形态出现了凋亡的特征,证明锑剂具有一定的诱导细胞凋亡的作用。Western Blot和免疫荧光共聚焦结果显示,锑剂同样可导致PML-RARa融合蛋白的溶性发生改变,最终降解其蛋白融合蛋白;而且出现大颗粒状的PML核小体,并且与SUMO-1共定位于细胞核,提示锑剂可促使PML-RARα融合蛋白进入PML核小体,进而促进融合蛋白的降解,其作用类似于砷剂。2)锑剂对PML或PML-RARa过表达293T细胞体系实验结果;分别用不同浓度的锑剂或不同时间处理PML和PML-RARa过表达293T细胞,锑剂同样能够改变PML或PML-RARa融合蛋白的溶性改变,与NB4细胞实验结果相吻合。3)锑剂和PSO(锑化合物)对PML突变体的作用结果;锑剂和砷剂都无法诱导PML突变体(A216V或L218P)的溶性改变或降解,而新型锑化合物PSO具有较强的诱导PML突变体的溶性发生改变。结论:锑剂具有类似于砷剂诱导急性早幼粒细胞白血病NB4细胞的分化的作用,并且锑剂的细胞毒性远低于比砷剂。进一步证明锑剂同样能够诱导PML和PML-RARα融合蛋白的溶性改变和降解其融合蛋白。锑剂和砷剂对PML突变体无作用,而新型锑化合物PSO具有较强的诱导砷剂耐药型PML突变蛋白降解,从而证明锑剂作用的广泛性。
[Abstract]:Objective: 1) of antimony agent in the treatment of acute promyelocytic leukemia (APL) in the role, to explore the impact of antimonials on acute promyelocytic leukemia related protein, and prove that APL.2 treatment agent with antimony antimony) through the study of mutant agent on PML (such as A216V and L218P; arsenic resistance mutant) the degradation effect of antimony compounds found has stronger degradation of PML mutants. Methods: acute promyelocytic leukemia NB4 cells, using three oxidation two antimony (the antimony agent) or arsenic trioxide (positive control) exposure of NB4 cells by MTT method, Wright Giemsa dye staining and flow cytometry. Western Blot, NB4 cell proliferation inhibition test, immunofluorescence methods such as differentiation, apoptosis index. Effects of antimony detection agent on nucleosome formation using immunofluorescence method. By using HEK293T or HeLa cells transfected with Flag-PML or Flag-PML-RARa Because, over expression of PML or PML-RARa fusion protein of antimonials (or arsenic) on PML protein solubility change and degradation. The main RIPA buffer and LDS buffer respectively to extract soluble supernatant protein (RIPA soluble fraction) and insoluble protein precipitation (RIPA insoluble part). Using the Western Blot method was used to detect PML PML-RARa and RIPA fusion protein in soluble and insoluble part of the change and modification changes. Results: 1) the effect of antimony agent on NB4 cells; MTT and flow cytometry showed that the cytotoxicity of antimonials was weaker than that of arsenic, antimony and agents have strong NB4 cells induced the expression of CD11b (early myeloid differentiation marker). At the same time, also found that antimonials can make NB morphological changes, that antimonials have strong NB4 cell differentiation effect. With the increase of antimony exposure concentration, cell morphology appeared apoptosis characteristics of proof agent with sb There are some apoptosis inducing effects of.Western Blot and confocal immunofluorescence results showed that antimonials can result in PML-RARa fusion protein solubility change, the final degradation of fusion proteins; and large granular PML nucleosomes, and SUMO-1 colocalized in the nucleus, suggesting that antimonials can promote PML-RAR alpha fusion protein PML into the nucleosome, and then promote the degradation of the fusion protein, its role is similar to arsenic antimony.2) agent on PML or PML-RARa cells overexpressing 293T system experimental results; respectively with different concentrations of antimony agents or different processing time of PML and PML-RARa cells overexpressing 293T, antimonials can also change the PML or PML-RARa fusion protein solubility change of NB4 cell and the experimental results were in good agreement with.3) and PSO (antimony antimony compounds) effect on results of PML mutant; antimony and arsenic trioxide can induce agent PML mutants (A216V or L2 18P) the solubility change or degradation, while the new antimony compound PSO has strong induction of PML mutant soluble change. Conclusion: Antimony is similar to arsenic induced acute promyelocytic leukemia NB4 cell differentiation, and cell toxicity of antimonials is far lower than the ratio of arsenic. Further proof of the same antimonials could induce PML and PML-RAR alpha fusion protein solubility change and degradation of its fusion protein. Antimony and arsenic trioxide had no effect on PML mutant, and new antimony compound PSO is induced by arsenic trioxide resistant PML strong mutant protein degradation, thus proving extensive antimonials.

【学位授予单位】:浙江大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R733.71

【相似文献】

相关期刊论文 前10条

1 董振舜;媄守仁;;口服锑剂亁仩囊制造实验[J];中国药学杂志;1958年10期

2 陆颂慈;;锑剂反应及其处理[J];中级医刊;1956年10期

3 刘锦桃;;锑剂短程疗法技术革新20条[J];中级医刊;1958年11期

4 陆希羽;;介绍锑剂和使君肉同时应用方法[J];江苏中医;1958年06期

5 赵中庸;;注射锑剂的几个问题[J];护理杂志;1959年03期

6 王永丰;;锑剂药物疹110例临床分析[J];云南医学杂志;1959年01期

7 周学章;皇甫铭;;锑剂反应的预防和处理[J];中级医刊;1960年04期

8 李汉蕴 ,徐炳祥 ,陈思义;口服缓解树脂锑剂的研究[J];南京药学院学报;1962年07期

9 郑成规;蒲玉田;韩仁良;;锑剂三天疗法所致精神失常一例报告[J];江西医药;1963年03期

10 梁炳学;;锑剂与阿、斯二氏综合征—附12例分析[J];云南医学杂志;1964年03期

相关博士学位论文 前1条

1 于文强;锑剂治疗早幼粒细胞白血病的基础与临床研究[D];第四军医大学;2001年

相关硕士学位论文 前1条

1 兰勇飞;锑剂治疗急性早幼粒细胞白血病的优势作用研究[D];浙江大学;2017年



本文编号:1546412

资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/zlx/1546412.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户abe8d***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com